TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Scientists at the University of Oxford demonstrate an approach to interpreting how materials interact with polarized light, ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

Paying homage to Parkway Drive's Ben Gordon, Polaris's Dan Furnari, Stray From The Path's Craig Reynolds & more The post RedHook’s Alex Powys Talks 10 Drummers Who Influenced His Playing On ‘Mutation’ ...

Elliptical retarder model improves polarization analysis for material design and biomedical imaging. The work, reported in Advanced Photonics Nexus, focuses on improving how researchers analyze a key ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, today ...

Iberdomide and mezigdomide are currently being evaluated for the treatment of patients with multiple myeloma in a number of trials, with results so far showing activity in relapsed or refractory ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

Scientists at the University of Oxford demonstrate an approach to interpreting how materials interact with polarized light, which could help advance ...

Multi-electrode arrays (MEAs) provide a noninvasive interface with sub-millisecond temporal resolution and long-term, ...